Alzheimer's and dementia: Understand wandering and how to address it

by From Mayo Clinic News NetworkCredit: CC0 Public DomainWandering and becoming lost is common among people with Alzheimer's disease or other disorders causing dementia. This behavior can happen i

Updated on: April 20,2024

Alzheimer's and dementia: Understand wandering and how to address it

by From Mayo Clinic News NetworkCredit: CC0 Public DomainWandering and becoming lost is common among people with Alzheimer's disease or other disorders causing dementia. This behavior can happen i

Updated on:April 20,2024

Protein modification of a gene expression regulator can confer neuroprotection against inflammation

by University of Eastern FinlandCredit: Public DomainResearchers at the University of Eastern Finland have found a potential neuroprotective effect of a protein modification that could be a thera

Updated on: June 14,2024

Protein modification of a gene expression regulator can confer neuroprotection against inflammation

by University of Eastern FinlandCredit: Public DomainResearchers at the University of Eastern Finland have found a potential neuroprotective effect of a protein modification that could be a thera

Updated on:June 14,2024

Care more expensive for dementia patients and families in last years of life

by The Mount Sinai HospitalThe cost of care over the last five years of life for patients with dementia is significantly higher than for patients who die from heart disease, cancer, or other caus

Updated on: February 26,2024

Care more expensive for dementia patients and families in last years of life

by The Mount Sinai HospitalThe cost of care over the last five years of life for patients with dementia is significantly higher than for patients who die from heart disease, cancer, or other caus

Updated on:February 26,2024

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A

Updated on: March 24,2024

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A

Updated on:March 24,2024

Report supports reparations for harm to Australians living with dementia

by University of Technology, SydneyCredit: Pixabay/CC0 Public DomainA new report aims to bring awareness to the need for reparations, as well as changes to policy and practice around access to ju

Updated on: April 29,2024

Report supports reparations for harm to Australians living with dementia

by University of Technology, SydneyCredit: Pixabay/CC0 Public DomainA new report aims to bring awareness to the need for reparations, as well as changes to policy and practice around access to ju

Updated on:April 29,2024

Brain stimulation treatment may improve depression, anxiety in older adults

byUniversity of FloridaCredit: Pixabay/CC0 Public DomainA noninvasive brain stimulation treatment improved depression and anxiety symptoms among older adults in a new University of Florida-led&n

Updated on: April 28,2024

Brain stimulation treatment may improve depression, anxiety in older adults

byUniversity of FloridaCredit: Pixabay/CC0 Public DomainA noninvasive brain stimulation treatment improved depression and anxiety symptoms among older adults in a new University of Florida-led&n

Updated on:April 28,2024

Clinical trial suggests new drug candidate for spinocerebellar ataxia may offer certain therapeutic benefits

byNiigata UniversityL-arginine inhibits the aggregation of polyglutamine proteins in neuronal cells. Credit: Niigata UniversityA team has conducted a trial on the efficacy and safety of L-argini

Updated on: December 18,2024

Clinical trial suggests new drug candidate for spinocerebellar ataxia may offer certain therapeutic benefits

byNiigata UniversityL-arginine inhibits the aggregation of polyglutamine proteins in neuronal cells. Credit: Niigata UniversityA team has conducted a trial on the efficacy and safety of L-argini

Updated on:December 18,2024

Simple test may predict cognitive impairment long before symptoms appear

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainIn people with no thinking and memory problems, a simple test may predict the risk of developing cognitive impairment years later,

Updated on: June 20,2024

Simple test may predict cognitive impairment long before symptoms appear

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainIn people with no thinking and memory problems, a simple test may predict the risk of developing cognitive impairment years later,

Updated on:June 20,2024

Genetic 'hotspots' that speed up and slow down brain aging could provide new targets for Alzheimer's drugs

by University of Southern CaliforniaCredit: CC0 Public DomainResearchers from a USC-led consortium have discovered 15 "hotspots" in the genome that either speed up brain aging or slow i

Updated on: June 20,2024

Genetic 'hotspots' that speed up and slow down brain aging could provide new targets for Alzheimer's drugs

by University of Southern CaliforniaCredit: CC0 Public DomainResearchers from a USC-led consortium have discovered 15 "hotspots" in the genome that either speed up brain aging or slow i

Updated on:June 20,2024

Pre-TBI headache affects diagnosis of posttraumatic headache

Individuals with headache before traumatic brain injury (TBI) are less likely to receive a diagnosis of posttraumatic headache (PTH), according to a study published online May 20 inHeadache.Zach

Updated on: February 05,2024

Pre-TBI headache affects diagnosis of posttraumatic headache

Individuals with headache before traumatic brain injury (TBI) are less likely to receive a diagnosis of posttraumatic headache (PTH), according to a study published online May 20 inHeadache.Zach

Updated on:February 05,2024

People who cannot read may be three times as likely to develop dementia

by American Academy of NeurologyCredit: CC0 Public DomainNew research has found that people who are illiterate, meaning they never learned to read or write, may have nearly three times greater ri

Updated on: May 05,2024

People who cannot read may be three times as likely to develop dementia

by American Academy of NeurologyCredit: CC0 Public DomainNew research has found that people who are illiterate, meaning they never learned to read or write, may have nearly three times greater ri

Updated on:May 05,2024

Expert offers perspective on experimental Alzheimer's disease drug

by Deb BalzerCredit: Pixabay/CC0 Public DomainAccording to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show

Updated on: April 18,2024

Expert offers perspective on experimental Alzheimer's disease drug

by Deb BalzerCredit: Pixabay/CC0 Public DomainAccording to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show

Updated on:April 18,2024